Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.0B | 2.2B | 1.9B | 1.9B |
| Cost of revenue | 1.7B | 1.8B | 1.6B | 1.6B |
| Gross profit | 318.3M | 426.0M | 303.4M | 318.3M |
| Operating expense | ||||
| Research & development | 226.2M | 174.2M | 235.9M | 204.0M |
| Selling general and admin | 326.3M | -164.8M | 291.5M | 392.0M |
| Other operating expenses | — | — | — | — |
| Operating income | -234.2M | -49.9M | -224.0M | -277.6M |
| Non operating interest income | ||||
| Income | 4.9M | 4.2M | 4.5M | 9.9M |
| Expense | 82.9M | 61.8M | 57.4M | 59.4M |
| Other income expense | 5.3M | -96.8M | -773.5M | -19.8M |
| Pretax income | -306.9M | -204.3M | -1.1B | -346.8M |
| Tax provision | 9.2M | -3.7M | 10.7M | 6.9M |
| Net income | -316.1M | -200.6M | -1.1B | -353.7M |
| Basic EPS | -0.2 | -0.1 | -0.7 | -0.3 |
| Diluted EPS | -0.2 | -0.1 | -0.7 | -0.3 |
| Basic average shares | 1.5B | 1.5B | 1.5B | 1.5B |
| Diluted average shares | 1.5B | 1.5B | 1.5B | 1.5B |
| EBITDA | -233.0M | -24.0M | -209.1M | -280.4M |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 2.2M | 3.7M | 3.9M | 542K |
| Preferred stock dividends | — | — | — | — |